Selective expansion and engraftment of human CD16+ NK cells in NOD/SCID mice

European Journal of Immunology

Volumn 35, Issue 12, 2005, Pages 3599-3609

  Harada, Hideki ^a   Suzu, Shinya ^a   Ito, Takaaki ^b   Okada, Seiji ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Animal model; Cellular proliferation NK cells; Transplantation; Tumor immunology

Indexed keywords

CD16 ANTIGEN; CD56 ANTIGEN; CD69 ANTIGEN; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA;

ADOPTIVE IMMUNOTHERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE MARROW; CANCER IMMUNOTHERAPY; CELL FUNCTION; CELL MATURATION; CELL POPULATION; CELL PROLIFERATION; CELL SELECTION; CORD BLOOD STEM CELL TRANSPLANTATION; ERYTHROLEUKEMIA; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOTHERAPY; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; LARGE GRANULAR LYMPHOCYTE; LIVER; MOUSE; NATURAL KILLER CELL; NONHUMAN; PERITONEAL CAVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCID MOUSE; SPLEEN; TISSUE DISTRIBUTION; TUMOR IMMUNOLOGY;

ANIMALS; ANTIGENS, CD; CELL DEATH; CELL LINE, TUMOR; CELL PROLIFERATION; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; FETAL BLOOD; HUMANS; IMMUNITY, NATURAL; K562 CELLS; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED NOD; MICE, SCID; RECEPTORS, IGG; TRANSDUCTION, GENETIC;

EID: 29744445301     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200535125     Document Type: Article

References (49)

1. Robertson, M. J. and Ritz, J., Biology and clinical relevance of human natural killer cells. Blood 1990. 76: 2421-2438.
2. Ljunggren, H. G. and Karre, K., In search of the 'missing self': MHC molecules and NK cell recognition. Immunol. Today 1990. 11: 237-244.
3. Moretta, L., Bottino, C., Pende, D., Mingari, M. C., Biassoni, R. and Moretta, A., Human natural killer cells: their origin, receptors and function. Eur. J. Immunol. 2002. 32: 1205-1212.
4. French, A. R. and Yokoyama, W. M., Natural killer cells and viral infections. Curr. Opin. Immunol. 2003. 15: 45-51.
5. Cooper, M. A., Fehniger, T. A. and Caligiuri, M. A., The biology of human natural killer-cell subsets. Trends Immunol. 2001. 22: 633-640.
6. Herberman, R. B., Cancer immunotherapy with natural killer cells. Semin. Oncol. 2002. 29: 27-30.
7. Wu, J. and Lanier, L. L., Natural killer cells and cancer. Adv. Cancer Res. 2003. 90: 127-156.
8. Ravetch, J. V. and Lanier, L. L., Immune Inhibitory receptors. Science 2000. 290: 84-89.
9. Moretta, A., Biassoni, R., Bottino, C., Mingari, M. C. and Moretta, L., Natural cytotoxicity receptors that trigger human NK-cell-mediated cytolysis. Immunol. Today 2000. 21: 228.
10. Lanier, L. L., On guard-activating NK cell receptors. Nat. Immunol. 2001. 2: 23-27.
11. Biassoni, R., Cantoni, C., Pende, D., Sivori, S., Parolini, S., Vitale, M., Bottino, C. and Moretta, A., Human natural killer cell receptors and co-receptors. Immunol. Rev. 2001. 181: 203-214.
12. Moretta, L., Bottino, C., Pende, D., Vitale, M., Mingari, M. C. and Moretta, A., Different checkpoints in human NK-cell activation. Trends Immunol 2004. 25: 670-676.
13. +-enriched cells from umbilical cord blood in NOD /LtSz-scid/scid mice. Blood 1997. 90: 85-96.
14. null) NOD/SCID mice are excellent recipients for studying human stem cell function. Blood 2000. 95: 3102-3105.
15. Shultz, L. D., Lang, P. A., Christianson, S. W., Gott, B., Lyons, B., Umeda, S. Leiter, E. et al., NOD/LtSz-Rag1null mice: an immunodeficient and radioresistant model for engraftment of human hematolymphoid cells, HIV infection, and adoptive transfer of NOD mouse diabetogenic T cells. J. Immunol 2000. 164: 2496-2507.
16. + T cell engraftment in beta2-microglobulin-deficient NOD-scid mice. J. Immunol 1997. 158: 3578-3586.
17. -/- double-mutant mice. Blood 2003. 102: 2522-2531.
18. null mice model. Blood 2003. 102: 873-880.
19. Beider, K., Nagler, A., Wald, O., Franitza, S., Dagan-Berger, M., Wald, H., Giladi, H. et al., Involvement of CXCR4 and IL-2 in the homing and retention of human NK and NK T cells to the bone marrow and spleen of NOD/SCID mice. Blood 2003. 102: 1951-1958.
20. + cells. Blood. 2003. 102: 127-135.
21. Silva, M. R., Hoffman, R., Srour, E. F. and Ascensao, J. L., Generation of human natural killer cells from immature progenitors does not require marrow stromal cells. Blood 1994. 84: 841-846.
22. + hematopoietic progenitor cells. Blood 1995. 85: 3538-3546.
23. + hematopoietic progenitor cells. Blood 1996. 87: 2632-2640.
24. + human natural killer cell progenitor that responds to interleukin-15. Blood 1998. 92: 3647-3657.
25. Cooper, M. A., Bush, J. E., Fehniger, T. A., VanDeusen, J. B., Waite, R. E., Liu, Y., Aguila, H. L. et al., In vivo evidence for a dependence on interleukin 15 for survival of natural killer cells. Blood 2002. 100: 3633-3638.
26. Domzig, W., Stadler, B. M. and Herberman., R. B., Interleukin 2 dependence of human natural killer (NK) cell activity. J. Immunol. 1983. 130: 1970-1973.
27. Lanier, L. L., Buck, D. W., Rhodes, L., Ding, A., Evans, E., Barney, C. and Phillips, J. H., Interleukin 2 activation of natural killer cells rapidly induces the expression and phosphorylation of the Leu-23 activation antigen. J. Exp. Med. 1988. 167: 1572-1585.
28. Carson, W. E., Giri, J. G., Lindemann, M. J., Linett, M. L., Ahdieh, M., Paxton, R., Anderson, D. et al., Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J. Exp. Med. 1994. 180: 1395-1403.
29. Harada, H., Saijo, K., Watanabe, S., Tsuboi, K., Nose, T., Ishiwata, I. and Ohno, T., Selective expansion of human natural killer cells from peripheral blood mononuclear cells by the cell line, HFWT. Jpn. J. Cancer Res. 2002. 93: 313.
30. Harada, H., Saijo, K., Ishiwata, I. and Ohno, T., A GFP-transfected HFWT cell line, GHINK-1, as a novel target for non-RI activated natural killer cytotoxicity assay. Hum. Cell 2004. 17: 43-48.
31. Simmons, D. and Seed, B., The Fc gamma receptor of natural killer cells is a phospholipid-linked membrane protein. Nature 1988. 333: 568-570.
32. Phillips, J. H., Hori, T., Nagler, A., Bhat, N., Spits, H. and Lanier, L. L., Ontogeny of human natural killer (NK) cells: fetal NK cells mediate cytolytic function and express cytoplasmic CD3 epsilon, delta proteins. J. Exp. Med. 1992. 175: 1055-1066.
33. - cells with low lytic activity are possible precursors of mature natural killer cells. Cell. Immunol. 1997. 180: 132-142.
34. + human natural killer cells and their novel precursors in blood mononuclear cells. Exp. Hematol. 2004. 32: 614-621.
35. Lyons, A. B., and Parish, C. R., Determination of lymphocyte division by flow cytometry. J. Immunol. Methods 1994. 171: 131-137.
36. Grimm, E. A., Mazumder, A., Zhang, H. Z. and Rosenberg, S. A., Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes. J. Exp. Med. 1982. 155: 1823-1841.
37. Robertson, M. J., Caligiuri, M. A., Manley, T. J., Levine, H. and Ritz, J., Human natural killer cell adhesion molecules: Differential expression after activation and participation in cytolysis. J. Immunol. 1990. 145: 3194-3201.
38. Vitale, M., Bottino, C., Sivori, S., Sanseverino, L., Castriconi, R., Marcenaro, E., Augugliaro, R. et al., NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis. J. Exp. Med. 1998. 187: 2065-2072.
39. Weichold, F. F., Jiang, Y. Z., Dunn, D. E., Bloom, M., Malkovska, V., Hensel, N. F. and Barrett, A. J., Regulation of a graft-versus-leukemia effect by major histocompatibility complex class II molecules on leukemia cells: HLA-DR1 expression renders K562 cell tumors resistant to adoptively transferred lymphocytes in severe combined immunodeficiency mice/nonobese diabetic mice. Blood 1997. 90: 4553-4558.
40. Kantakamalakul, W., Jaroenpool, J. and Pattanapanyasat, K., A novel enhanced green fluorescent protein (EGFP)-K562 flowcytometric method for measuring natural killer (NK) cell cytotoxic activity. J. Immunol. Methods 2003. 272: 189-197.
41. + NK progenitor. Blood 1994. 83: 2594-2601.
42. + progenitors to peripheral blood. J. Exp. Med. 1997. 185: 111-120.
43. Robertson, M. J., Role of chemokines in the biology of natural killer cells. J. Leukoc. Biol. 2002. 71: 173-183.
44. Ferlazzo, G., Tsang, M. L., Moretta, L., Melioli, G., Steinman, R. M. and Munz, C., Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J. Exp. Med 2002. 195: 343-351.
45. Nagler, A., Lanier, L. L. Quirt, S. and Phillips, J. H., Comparative studies of human FcRIII-positive and negative natural killer cells. J. Immunol. 1989. 143: 3183-3191.
46. Rosenberg, S. A., Lotze, M. T., Muul, L. M., Leitman, S., Chang, A. E., Ettinghausen, S. E., Matory, Y. L., et al., Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. N. Engl. J. Med. 1985. 313: 1485-1492.
47. Khatri, V. P., Fehniger, T. A., Baiocchi, R. A., Yu, F., Shah, M. H., Schiller, D. S., Gould, M. et al., Ultra low dose interleukin-2 therapy promotes a type 1 cytokine profile in vivo in patients with AIDS and AIDS-associated malignancies. J. Clin. Invest. 1998. 101: 1373-1378.
48. Fehniger, T. A. and Caligiuri, M. A., Interleukin 15: biology and relevance to human disease. Blood 2001. 97: 14-32.
49. Attia, M.A. and Weiss, D. W., Immunology of spontaneous mammary carcinomas in mice. V. Acquired tumor resistance and enhancement in strain A mice infected with mammary tumor virus. Cancer Res. 1966. 26: 1787-1800.